Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ULTOMIRIS
- Pharmacokinetic Study of Ravulizumab Administered Subcutaneously With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult Volunteers
- Phase 2/3 Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
- A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants
- A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants
- A Study of Multiple Doses of ALXN1210 in Healthy Adult Participants
- A Study of a Single Dose of ALXN1210 in Healthy Participants
- Ravulizumab-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Co
- Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
- Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis
- Ravulizumab and COVID-19
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Study of Ravulizumab in Pediatric Participants With HSCT-TMA
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
- mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
- An Efficacy and Safety Study of Ravulizumab in ALS Participants
- Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Clinical trials list
click for details